GB201211019D0 - Inhibitor compounds - Google Patents
Inhibitor compoundsInfo
- Publication number
- GB201211019D0 GB201211019D0 GBGB1211019.3A GB201211019A GB201211019D0 GB 201211019 D0 GB201211019 D0 GB 201211019D0 GB 201211019 A GB201211019 A GB 201211019A GB 201211019 D0 GB201211019 D0 GB 201211019D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- inhibitor compounds
- inhibitor
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1211019.3A GB201211019D0 (en) | 2012-06-21 | 2012-06-21 | Inhibitor compounds |
| PCT/GB2013/051634 WO2013190320A1 (en) | 2012-06-21 | 2013-06-21 | Imidazopyridines as inhibitors of aurora kinase and/or flt3 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1211019.3A GB201211019D0 (en) | 2012-06-21 | 2012-06-21 | Inhibitor compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB201211019D0 true GB201211019D0 (en) | 2012-08-01 |
Family
ID=46641295
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB1211019.3A Ceased GB201211019D0 (en) | 2012-06-21 | 2012-06-21 | Inhibitor compounds |
Country Status (2)
| Country | Link |
|---|---|
| GB (1) | GB201211019D0 (en) |
| WO (1) | WO2013190320A1 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201502020D0 (en) * | 2015-02-06 | 2015-03-25 | Cancer Rec Tech Ltd | Autotaxin inhibitory compounds |
| WO2020185856A1 (en) * | 2019-03-11 | 2020-09-17 | The Children's Medical Center Corporation | Methods for increasing platelet production |
| AU2020367204A1 (en) * | 2019-10-15 | 2022-04-14 | Aucentra Therapeutics Pty Ltd | Derivatives of 4-(imidazo[1,2-a]pyridin-3-yl)-N-(pyridin-3-yl) pyrimidin-2- amine for treating proliferative diseases and conditions |
| CN118561748B (en) * | 2024-07-25 | 2024-09-27 | 山东仁一生物科技有限责任公司 | Method for preparing 2-amino-4-chloro-5-nitropyridine |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007072017A2 (en) * | 2005-12-22 | 2007-06-28 | The Institute Of Cancer Research | Enzyme inhibitors |
| WO2009001021A1 (en) * | 2007-06-26 | 2008-12-31 | Chroma Therapeutics Ltd. | Imidazopyridine derivatives useful as enzyme inhibitors for the treatment of cell proliferative and autoimmune diseases |
-
2012
- 2012-06-21 GB GBGB1211019.3A patent/GB201211019D0/en not_active Ceased
-
2013
- 2013-06-21 WO PCT/GB2013/051634 patent/WO2013190320A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2013190320A1 (en) | 2013-12-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL268013A (en) | Tetrahydropyrazolopyrimidine compounds | |
| SI2892889T1 (en) | Inhibitor compounds | |
| EP2804479A4 (en) | Metalloenzyme inhibitor compounds | |
| AP2014007810A0 (en) | Imidazopyrrolidinone compounds | |
| IL237341A0 (en) | Pro-neurogenic compounds | |
| GB201209138D0 (en) | Compounds | |
| GB201215357D0 (en) | Compounds | |
| GB201214750D0 (en) | Compounds | |
| EP2894981A4 (en) | Metalloenzyme inhibitor compounds | |
| PL2804858T3 (en) | Metalloenzyme inhibitor compounds | |
| EP2828262A4 (en) | Imidazotriazinone compounds | |
| GB201204985D0 (en) | Compounds | |
| GB201204125D0 (en) | Compounds | |
| PL2836495T3 (en) | Tetrahydropyrrolothiazine compounds | |
| GB201209096D0 (en) | Compounds | |
| IL235919A0 (en) | Fbxo3 inhibitors | |
| GB201219820D0 (en) | Compounds | |
| GB201211019D0 (en) | Inhibitor compounds | |
| GB201217310D0 (en) | Compounds | |
| TWI561515B (en) | Metalloenzyme inhibitor compounds | |
| GB201223429D0 (en) | Compounds | |
| GB201220029D0 (en) | Compounds | |
| GB201219819D0 (en) | Compounds | |
| GB201218799D0 (en) | Compounds | |
| GB201218776D0 (en) | Compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |